2
Clinical Trials associated with Adipose-derived MesenchymAl Stem Cells(Rigshospitalet) / Not yet recruitingPhase 1/2IIT Intraglandular treatment with adipose derived mesenchymal stem cells in patients with xerostomia due to Sjögrens syndrome (ASSIX)
A Randomized Clinical Trial Evaluating Allogeneic Adipose-derived MesenchymAl Stem Cells as a Treatment of Dry Eye Disease in Patients With Sjögren's Syndrome
AMASS is a double-blinded randomized clinical trial with the purpose of investigating whether injection of allogeneic adipose-derived mesenchymal stem cells (ASCs) into the lacrimal gland (LG) results in increased ocular comfort compared to placebo.
100 Clinical Results associated with Adipose-derived MesenchymAl Stem Cells(Rigshospitalet)
100 Translational Medicine associated with Adipose-derived MesenchymAl Stem Cells(Rigshospitalet)
100 Patents (Medical) associated with Adipose-derived MesenchymAl Stem Cells(Rigshospitalet)
100 Deals associated with Adipose-derived MesenchymAl Stem Cells(Rigshospitalet)